Validation of prognostic biomarkers for RA: Testing of 14-3-3 eta according to the omeract soluble biomarker criteria.

W.P. Maksymowych; D. Van der Heijde; R. Landewe; G.A. Wells; J.M. Bathon; C.O. Bingham III; V.P. Bykerk; Mikkel Østergaard; M.B. Hammer; M. Boers; P.P. Tak; O.M. FizGerald; C.T. Ritchlin; D. Gladman; P. Mease; S. van Schaardenburg; M. Backhaus; B. Combe; G. Ferraccioli; A. Marotta

Validation of prognostic biomarkers for RA: Testing of 14-3-3 eta according to the omeract soluble biomarker criteria.

W.P. Maksymowych, D. Van der Heijde, R. Landewe, G.A. Wells, J.M. Bathon, C.O. Bingham III, V.P. Bykerk, Mikkel Østergaard, M.B. Hammer, M. Boers, P.P. Tak, O.M. FizGerald, C.T. Ritchlin, D. Gladman, P. Mease, S. van Schaardenburg, M. Backhaus, B. Combe, G. Ferraccioli, A. Marotta

Originalsprog	Engelsk
Tidsskrift	Arthritis & Rheumatism
Vol/bind	64
Udgave nummer	10 Suppl.
Sider (fra-til)	S896
Antal sider	1
ISSN	0004-3591
Status	Udgivet - 2012

Citationsformater

Maksymowych, W. P., Van der Heijde, D., Landewe, R., Wells, G. A., Bathon, J. M., Bingham III, C. O., Bykerk, V. P., Østergaard, M., Hammer, M. B., Boers, M., Tak, P. P., FizGerald, O. M., Ritchlin, C. T., Gladman, D., Mease, P., van Schaardenburg, S., Backhaus, M., Combe, B., Ferraccioli, G., & Marotta, A. (2012). Validation of prognostic biomarkers for RA: Testing of 14-3-3 eta according to the omeract soluble biomarker criteria. Arthritis & Rheumatism, 64(10 Suppl.), S896.

Maksymowych, WP, Van der Heijde, D, Landewe, R, Wells, GA, Bathon, JM, Bingham III, CO, Bykerk, VP, Østergaard, M, Hammer, MB, Boers, M, Tak, PP, FizGerald, OM, Ritchlin, CT, Gladman, D, Mease, P, van Schaardenburg, S, Backhaus, M, Combe, B, Ferraccioli, G & Marotta, A 2012, 'Validation of prognostic biomarkers for RA: Testing of 14-3-3 eta according to the omeract soluble biomarker criteria.', Arthritis & Rheumatism, bind 64, nr. 10 Suppl., s. S896.

@article{a18550036ea24147bf37a560831b5339,

title = "Validation of prognostic biomarkers for RA: Testing of 14-3-3 eta according to the omeract soluble biomarker criteria.",

author = "W.P. Maksymowych and {Van der Heijde}, D. and R. Landewe and G.A. Wells and J.M. Bathon and {Bingham III}, C.O. and V.P. Bykerk and Mikkel {\O}stergaard and M.B. Hammer and M. Boers and P.P. Tak and O.M. FizGerald and C.T. Ritchlin and D. Gladman and P. Mease and {van Schaardenburg}, S. and M. Backhaus and B. Combe and G. Ferraccioli and A. Marotta",

year = "2012",

language = "English",

volume = "64",

pages = "S896",

journal = "Arthritis & Rheumatism",

issn = "0004-3591",

publisher = "John Wiley & Sons Inc.",

number = "10 Suppl.",

}

TY - ABST

T1 - Validation of prognostic biomarkers for RA: Testing of 14-3-3 eta according to the omeract soluble biomarker criteria.

AU - Maksymowych, W.P.

AU - Van der Heijde, D.

AU - Landewe, R.

AU - Wells, G.A.

AU - Bathon, J.M.

AU - Bingham III, C.O.

AU - Bykerk, V.P.

AU - Østergaard, Mikkel

AU - Hammer, M.B.

AU - Boers, M.

AU - Tak, P.P.

AU - FizGerald, O.M.

AU - Ritchlin, C.T.

AU - Gladman, D.

AU - Mease, P.

AU - van Schaardenburg, S.

AU - Backhaus, M.

AU - Combe, B.

AU - Ferraccioli, G.

AU - Marotta, A.

PY - 2012

Y1 - 2012

M3 - Conference abstract in journal

SN - 0004-3591

VL - 64

SP - S896

JO - Arthritis & Rheumatism

JF - Arthritis & Rheumatism

IS - 10 Suppl.

ER -